Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Ulcerative Colitis Market by Drug Type (Anti-Inflammatory Drugs, Anti-TNF biologics, Immunosuppressant, Calcineurin Inhibitors, and Other Drug Types), Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), Regional Forecasts 2021-2027

  • BIZ4636269
  • 200 Pages
  • August 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Ulcerative Colitis Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2021-2027. Ulcerative colitis (UCs) is a chronic, inflammatory condition affecting the colon or large intestine. However, researchers think that it is an excessive reaction to a microbial stimulus, the origin of ulcerative colitis is not recognized. The UC is characterized by colon inflammation and has symptoms of stool blood, diarrhoea, and abdominal discomfort. UC is more frequent between men and has a geographical variance from north to south. One possible explanation is the variations in exposure to UV radiation that contribute to a relative deficit in vitamin D in Arctic regions. People living in lower latitudes will develop UC more often than people living in greater latitudes. The market is driven by increase in patient assistance programs and growing incidence and prevalence of Ulcerative Colitis worldwide. For instance, Ulcerative colitis occurs in 9-20 instances per 100,000 people per year globally, according to a Whitney D. Lynch et al. research report released by the NCBI (National Center for Biotechnology Information, June 2020). It is 156 to 291 cases per 100,000 individuals annually. The prevalence of ulcerate colitis in adulthood is higher. In non-smokers or those who recently stopped smoking, there is an increased prevalence of ulcerative colitis. However, side-effects of medications may impede market growth over the forecast period of 2021-2027.

Geographically, North America is dominating the ulcerative colitis market, due to increasing prevalence of Ulcerative Colitis and the presence of key players in the region, beside the ongoing funding for the development of new therapeutics for the treatment of the condition.

Major market player included in this report are:

Takeda Pharmaceutical Company Limited

AbbVie Inc. (Allergan, Inc.)

Boehringer Ingelheim GmbH

Bausch Health Companies Inc.

Johnson and Johnson

Teva Pharmaceutical Industries Ltd

Eli Lilly and Company

Bridge Biotherapeutics, Inc.

Pfizer Inc.

Arena Pharmaceuticals, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug type:

Anti-Inflammatory Drugs

Anti-TNF biologics

Immunosuppressant

Calcineurin Inhibitors

Other Drug Types

By Disease type:

Ulcerative Proctitis

Proctosigmoiditis

Left-sided Colitis

Pancolitis or Universal Colitis

Fulminant Colitis

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027.

Target Audience of the Global Ulcerative Colitis Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Ulcerative Colitis Market, by Region, 2019-2027 (USD Billion)

1.2.2. Ulcerative Colitis Market, by Drug, 2019-2027 (USD Billion)

1.2.3. Ulcerative Colitis Market, by Disease, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Ulcerative Colitis Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Ulcerative Colitis Market Dynamics

3.1. Ulcerative Colitis Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increase in patient assistance programs

3.1.1.2. Growing incidence and prevalence of Ulcerative Colitis

3.1.2. Market Restraint

3.1.2.1. Side-effects of medications

3.1.2.2. High levels of unmet clinical need in Ulcerative Colitis

3.1.3. Market Opportunities

3.1.3.1. Huge R&D and investment done by key players

Chapter 4. Global Ulcerative Colitis Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Ulcerative Colitis Market, by Drug

5.1. Market Snapshot

5.2. Global Ulcerative Colitis Market by Drug, Performance - Potential Analysis

5.3. Global Ulcerative Colitis Market Estimates & Forecasts by Drug 2018-2027 (USD Billion)

5.4. Ulcerative Colitis Market , Sub Segment Analysis

5.4.1. Anti-Inflammatory Drugs

5.4.2. Anti-TNF biologics

5.4.3. Immunosuppressant

5.4.4. Calcineurin Inhibitors

5.4.5. Other Drug Types

Chapter 6. Global Ulcerative Colitis Market, by Disease

6.1. Market Snapshot

6.2. Global Ulcerative Colitis Market by Disease, Performance - Potential Analysis

6.3. Global Ulcerative Colitis Market Estimates & Forecasts by Disease 2018-2027 (USD Billion)

6.4. Ulcerative Colitis Market , Sub Segment Analysis

6.4.1. Ulcerative Proctitis

6.4.2. Proctosigmoiditis

6.4.3. Left-sided Colitis

6.4.4. Pancolitis or Universal Colitis

6.4.5. Fulminant Colitis

Chapter 7. Global Ulcerative Colitis Market, Regional Analysis

7.1. Ulcerative Colitis Market , Regional Market Snapshot

7.2. North America Ulcerative Colitis Market

7.2.1. U.S. Ulcerative Colitis Market

7.2.1.1. Drug breakdown estimates & forecasts, 2018-2027

7.2.1.2. Disease breakdown estimates & forecasts, 2018-2027

7.2.2. Canada Ulcerative Colitis Market

7.3. Europe Ulcerative Colitis Market Snapshot

7.3.1. U.K. Ulcerative Colitis Market

7.3.2. Germany Ulcerative Colitis Market

7.3.3. France Ulcerative Colitis Market

7.3.4. Spain Ulcerative Colitis Market

7.3.5. Italy Ulcerative Colitis Market

7.3.6. Rest of Europe Ulcerative Colitis Market

7.4. Asia-Pacific Ulcerative Colitis Market Snapshot

7.4.1. China Ulcerative Colitis Market

7.4.2. India Ulcerative Colitis Market

7.4.3. Japan Ulcerative Colitis Market

7.4.4. Australia Ulcerative Colitis Market

7.4.5. South Korea Ulcerative Colitis Market

7.4.6. Rest of Asia Pacific Ulcerative Colitis Market

7.5. Latin America Ulcerative Colitis Market Snapshot

7.5.1. Brazil Ulcerative Colitis Market

7.5.2. Mexico Ulcerative Colitis Market

7.6. Rest of The World Ulcerative Colitis Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Takeda Pharmaceutical Company Limited

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. AbbVie Inc. (Allergan, Inc.)

8.2.3. Boehringer Ingelheim GmbH

8.2.4. Bausch Health Companies Inc.

8.2.5. Johnson and Johnson

8.2.6. Teva Pharmaceutical Industries Ltd

8.2.7. Eli Lilly and Company

8.2.8. Bridge Biotherapeutics, Inc.

8.2.9. Pfizer Inc.

8.2.10. Arena Pharmaceuticals, Inc.

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Ulcerative Colitis Market, report scope

TABLE 2. Global Ulcerative Colitis Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 3. Global Ulcerative Colitis Market estimates & forecasts by Drug 2018-2027 (USD Billion)

TABLE 4. Global Ulcerative Colitis Market estimates & forecasts by Disease 2018-2027 (USD Billion)

TABLE 5. Global Ulcerative Colitis Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 6. Global Ulcerative Colitis Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Ulcerative Colitis Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Ulcerative Colitis Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Ulcerative Colitis Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Ulcerative Colitis Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Ulcerative Colitis Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Ulcerative Colitis Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Ulcerative Colitis Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Ulcerative Colitis Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Ulcerative Colitis Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Ulcerative Colitis Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Ulcerative Colitis Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Ulcerative Colitis Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Global Ulcerative Colitis Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Global Ulcerative Colitis Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. U.S. Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. U.S. Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. U.S. Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. Canada Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. Canada Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Canada Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. UK Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. UK Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. UK Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. Germany Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. Germany Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. Germany Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. France Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. France Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. France Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. Spain Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. Spain Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Spain Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Italy Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. Italy Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Italy Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. ROE Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. ROE Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. ROE Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. China Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. China Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. China Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. India Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. India Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. India Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. Japan Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. Japan Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Japan Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Australia Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 55. Australia Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. Australia Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 57. South Korea Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 58. South Korea Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 59. South KoreaUlcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 60. ROPAC Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 61. ROPAC Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 62. ROPAC Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 63. Brazil Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 64. Brazil Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 65. Brazil Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 66. Mexico Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 67. Mexico Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 68. Mexico Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 69. ROLA Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 70. ROLA Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 71. ROLA Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 72. ROW Ulcerative Colitis Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 73. ROW Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 74. ROW Ulcerative Colitis Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 75. List of secondary sources used in the study of Global Ulcerative Colitis Market.

TABLE 76. List of primary sources used in the study of Global Ulcerative Colitis Market.

TABLE 77. Years considered for the study.

TABLE 78. Exchange rates considered.

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
View Details
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
View Details
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research